proč Velikost školní známka blok signalů bap 1 Galaxie Kariéra Deter
BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal Mesothelioma | bioRxiv
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s
Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer
BAP1 regulates IP3R3-mediated Ca 2+ flux to mitochondria suppressing cell transformation | Nature
BAP1 (D1W9B) Rabbit mAb
The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma | Cancer Research
Cancers | Free Full-Text | Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives | HTML
Oncogenic signaling in uveal melanoma - Park - 2018 - Pigment Cell & Melanoma Research - Wiley Online Library
Irradiation (IR) induces phosphorylation of BRCA1-associated protein 1... | Download Scientific Diagram
Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1 , CDKN2A , and NF2 gene deletions in peritoneal mesothelioma | Modern Pathology
Update on uveal melanoma: Translational research from biology to clinical practice (Review)
Cancers | Free Full-Text | Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology | HTML
Opposite Roles of BAP1 in Overall Survival of Uveal Melanoma and Cutaneous Melanoma
BAP1 Antibody (BSB-109) - Bio SB
BAP1 Missense Mutations in Cancer: Friend or Foe? - ScienceDirect
BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers | Science Advances
Mutations in IDH1 , BAP1 and CTNNB1 . (A) IDH1 is mutated in two... | Download Scientific Diagram
Cancers | Free Full-Text | Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology | HTML
Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma | BMC Medical Genomics | Full Text
BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma | bioRxiv